| Literature DB >> 31109003 |
Yafei Wang1,2, Jiaxing Wu3,4, Yuanjian Qiu5,6, Sagheer Atta7, Changyong Zhou8,9, Mengji Cao10,11.
Abstract
Citrus exocortis viroid (CEVd) is the causal agent of citrus exocortis disease. We employed CEVd-infected 'Etrog' citron as a system to study the feedback regulation mechanism using transcriptome analysis in this study. Three months after CEVd infection, the transcriptome of fresh leaves was analyzed, and 1530 differentially expressed genes were detected. The replication of CEVd in citron induced upregulation of genes encoding key proteins that were involved in the RNA silencing pathway such as Dicer-like 2, RNA-dependent RNA polymerase 1, argonaute 2, argonaute 7, and silencing defective 3, as well as those genes encoding proteins that are related to basic defense responses. Many genes involved in secondary metabolite biosynthesis and chitinase activity were upregulated, whereas other genes related to cell wall and phytohormone signal transduction were downregulated. Moreover, genes encoding disease resistance proteins, pathogenicity-related proteins, and heat shock cognate 70 kDa proteins were also upregulated in response to CEVd infection. These results suggest that basic defense and RNA silencing mechanisms are activated by CEVd infection, and this information improves our understanding of the pathogenesis of viroids in woody plants.Entities:
Keywords: Citrus exocortis viroid (CEVd); RNA silencing; differentially expressed genes; innate immunity; transcriptome; ‘Etrog’ citron
Year: 2019 PMID: 31109003 PMCID: PMC6563217 DOI: 10.3390/v11050453
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Figure 1Primary and secondary structures of CEVd variant, and disease symptoms of citron plants infected with the CEVd variant. (A) The positions of nucleotides in CEVd variant used in this study that differ from CEVd-Reference (NC_001464). (B) One-step RT-PCR products of CEVd-infected citrus materials. (C) One-step RT-PCR analysis of CEVd-inoculated citron. (D) Northern blot hybridization using specific probes of nucleic acid preparations derived from CEVd-infected tomato leaves and healthy control. (E) Different symptoms between citron plants inoculated with the CEVd variant and healthy control. M, BM2000 DNA marker; 1 and 3, viroid-free samples; 2, CEVd-infected sample; 4, ‘Etrog’ citron inoculated with CEVd RNA transcripts; a, Northern blot; b, RNA control; HC, healthy control.
Figure 2Disease symptoms of citron plants after grafting for 3 months.
The quality of sequencing data.
| Sample Name | Raw Reads | Clean Reads | Clean Bases | Q20 (%) | Q 30(%) | GC Content (%) |
|---|---|---|---|---|---|---|
| HC1 | 86,594,558 | 83,854,342 | 12.45G | 97.66 | 93.99 | 44.75 |
| HC2 | 73,264,886 | 68,562,642 | 10.16G | 97.51 | 94.13 | 48.73 |
| HC3 | 95,947,986 | 89,863,580 | 13.24G | 97.68 | 94.31 | 44.36 |
| CEV1 | 117,995,510 | 113,662,956 | 16.91G | 97.72 | 94.10 | 44.35 |
| CEV2 | 107,136,484 | 104,075,096 | 15.50G | 97.87 | 94.72 | 42.76 |
| CEV3 | 80,867,964 | 75,965,424 | 11.32G | 97.73 | 94.39 | 42.65 |
Figure 3Volcano map of the differential genes. Genes with significant differential expression were indicated by red dots (upregulated) and green dots (downregulated). Genes with no significant differential expression were represented by blue dots.
Enriched GO terms for the upregulated DEGs in CEVd-infected citron plants.
| GO Accession | Description | Term Type | Corrected |
|---|---|---|---|
| GO:0006351 | transcription, DNA-templated | BP | 8.13 × 10−5 |
| GO:0097659 | nucleic acid-templated transcription | BP | 8.13 × 10−5 |
| GO:0032774 | RNA biosynthetic process | BP | 8.13 × 10−5 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | BP | 8.13 × 10−5 |
| GO:0006355 | regulation of transcription, DNA-templated | BP | 8.13 × 10−5 |
| GO:1903506 | regulation of nucleic acid-templated transcription | BP | 8.13 × 10−5 |
| GO:0051252 | regulation of RNA metabolic process | BP | 8.13 × 10−5 |
| GO:2001141 | regulation of RNA biosynthetic process | BP | 8.13× 10−5 |
| GO:0006030 | chitin metabolic process | BP | 8.13 × 10−5 |
| GO:1901071 | glucosamine-containing compound metabolic process | BP | 8.13 × 10−5 |
| GO:0006032 | chitin catabolic process | BP | 8.13 × 10−5 |
| GO:0046348 | amino sugar catabolic process | BP | 8.13 × 10−5 |
| GO:1901072 | glucosamine-containing compound catabolic process | BP | 8.13 × 10−5 |
| GO:0016998 | cell wall macromolecule catabolic process | BP | 0.000133 |
| GO:0006026 | aminoglycan catabolic process | BP | 0.000133 |
| GO:2000112 | regulation of cellular macromolecule biosynthetic process | BP | 0.001066 |
| GO:0006040 | amino sugar metabolic process | BP | 0.001132 |
| GO:0010556 | regulation of macromolecule biosynthetic process | BP | 0.001132 |
| GO:0031326 | regulation of cellular biosynthetic process | BP | 0.001132 |
| GO:0009889 | regulation of biosynthetic process | BP | 0.001235 |
| GO:0051171 | regulation of nitrogen compound metabolic process | BP | 0.001391 |
| GO:0034654 | nucleobase-containing compound biosynthetic process | BP | 0.002117 |
| GO:0044036 | cell wall macromolecule metabolic process | BP | 0.004343 |
| GO:0010468 | regulation of gene expression | BP | 0.004949 |
| GO:0080090 | regulation of primary metabolic process | BP | 0.006186 |
| GO:0031323 | regulation of cellular metabolic process | BP | 0.00663 |
| GO:0060255 | regulation of macromolecule metabolic process | BP | 0.009714 |
| GO:0018130 | heterocycle biosynthetic process | BP | 0.013439 |
| GO:1901362 | organic cyclic compound biosynthetic process | BP | 0.013439 |
| GO:0006022 | aminoglycan metabolic process | BP | 0.014413 |
| GO:0019438 | aromatic compound biosynthetic process | BP | 0.015638 |
| GO:0019222 | regulation of metabolic process | BP | 0.02637 |
| GO:0043207 | response to external biotic stimulus | BP | 0.033447 |
| GO:0051707 | response to other organism | BP | 0.033447 |
| GO:0006468 | protein phosphorylation | BP | 0.040882 |
| GO:0004568 | chitinase activity | MF | 8.13 × 10−5 |
| GO:0001071 | nucleic acid binding transcription factor activity | MF | 0.000204 |
| GO:0003700 | transcription factor activity, sequence-specific DNA binding | MF | 0.000204 |
| GO:0004674 | protein serine/threonine kinase activity | MF | 0.000761 |
| GO:0004672 | protein kinase activity | MF | 0.014413 |
| GO:0008061 | chitin binding | MF | 0.0321 |
| GO:0020037 | heme binding | MF | 0.033855 |
BP, biological process; CC, cellular component; MF, molecular function.
Enriched GO terms for the downregulated DEGs in CEVd-infected citron plants.
| GO Accession | Description | Term Type | Corrected |
|---|---|---|---|
| GO:0009733 | response to auxin | BP | 1.70 × 10−6 |
| GO:0009725 | response to hormone | BP | 1.07 × 10−5 |
| GO:0009719 | response to endogenous stimulus | BP | 1.07 × 10−5 |
| GO:0010033 | response to organic substance | BP | 3.29 × 10−5 |
| GO:0045229 | external encapsulating structure organization | BP | 0.002848 |
| GO:0044264 | cellular polysaccharide metabolic process | BP | 0.004845 |
| GO:0009832 | plant-type cell wall biogenesis | BP | 0.004996 |
| GO:0010215 | cellulose microfibril organization | BP | 0.004996 |
| GO:0030198 | extracellular matrix organization | BP | 0.004996 |
| GO:0043062 | extracellular structure organization | BP | 0.004996 |
| GO:0070726 | cell wall assembly | BP | 0.004996 |
| GO:0071668 | plant-type cell wall assembly | BP | 0.004996 |
| GO:0042221 | response to chemical | BP | 0.007365 |
| GO:0071555 | cell wall organization | BP | 0.007365 |
| GO:0006073 | cellular glucan metabolic process | BP | 0.007365 |
| GO:0044042 | glucan metabolic process | BP | 0.007365 |
| GO:0005976 | polysaccharide metabolic process | BP | 0.008838 |
| GO:0016049 | cell growth | BP | 0.013705 |
| GO:0044262 | cellular carbohydrate metabolic process | BP | 0.025726 |
| GO:0009664 | plant-type cell wall organization | BP | 0.027923 |
| GO:0071669 | plant-type cell wall organization or biogenesis | BP | 0.027923 |
| GO:0042546 | cell wall biogenesis | BP | 0.036742 |
| GO:0071554 | cell wall organization or biogenesis | BP | 0.037842 |
| GO:0040007 | growth | BP | 0.038351 |
| GO:0005618 | cell wall | CC | 0.004996 |
| GO:0031225 | anchored component of membrane | CC | 0.007945 |
| GO:0030312 | external encapsulating structure | CC | 0.018609 |
| GO:0005507 | copper ion binding | MF | 9.43 × 10−5 |
BP, biological process; CC, cellular component; MF, molecular function.
KEGG pathway enrichment of DEGs from CEVd-infected citron plants.
| Term | ID | Input Number | Background Number | Corrected |
|---|---|---|---|---|
|
| ||||
| Glutathione metabolism | cit00480 | 18 | 95 | 6.45 × 10−6 |
| Plant-pathogen interaction | cit04626 | 18 | 208 | 0.044203 |
| Biosynthesis of secondary metabolites | cit01110 | 52 | 930 | 0.047811 |
| Amino sugar and nucleotide sugar metabolism | cit00520 | 12 | 120 | 0.047811 |
|
| ||||
| Plant hormone signal transduction | cit04075 | 10 | 217 | 0.000251 |
| Phenylpropanoid biosynthesis | cit00940 | 7 | 159 | 0.004052 |
| Phenylalanine metabolism | cit00360 | 5 | 115 | 0.022122 |
Effect of the genes involved in plant-pathogen interactions in CEVd-infected citron plants.
| Gene ID | log2 Fold Change | Function | |
|---|---|---|---|
| Cm116590 | 1.5929 | 0.048035 | DRL27: Disease resistance protein At4g27190 |
| Cm029390 | 6.1457 | 2.21 × 10−18 | RBOHD: Respiratory burst oxidase homolog protein D |
| Cm070920 | 1.6338 | 0.020128 | EFTM: Elongation factor Tu, mitochondrial |
| Cm216070 | Inf * | 5.50 × 10−7 | CML8: Calmodulin-like protein 8 |
| Cm056030 | 6.7263 | 3.39 × 10−24 | CML19: Putative calcium-binding protein CML19 |
| Cm113060 | 2.7079 | 4.10 × 10−6 | CML27: Probable calcium-binding protein CML27 |
| Cm128110 | 5.2652 | 0.00012824 | CML31: Probable calcium-binding protein CML31 |
| Cm040570 | 3.4838 | 1.15 × 10−7 | CML44: Probable calcium-binding protein CML44 |
| Cm241600 | 3.0724 | 4.07 × 10−7 | ALLB3: Calcium-binding allergen Bet v 3 |
| Cm050430 | 2.513 | 0.00030948 | ALL8: Calcium-binding allergen Ole e 8 |
| Novel01586 | –2.1223 | 0.036209 | PREDICTED: calcium-dependent protein kinase 9-like |
| Cm106570 | 4.4746 | 2.62 × 10−6 | CNG13: Putative cyclic nucleotide-gated ion channel 13 |
| Cm226290 | 2.8711 | 0.00020247 | WRK33: Probable WRKY transcription factor 33 |
| Cm011420 | 3.1569 | 9.55 × 10−8 | TIF9: Protein TIFY 9 |
| Cm220810 | 3.0776 | 3.14 × 10−6 | TI10A: Protein TIFY 10A |
| Cm157630 | 4.425 | 3.17 × 10−8 | TI10A: Protein TIFY 10A |
| Cm199700 | 3.0945 | 0.0029031 | CERK1: Chitin elicitor receptor kinase 1 |
| Cm178700 | 4.3046 | 0.030672 | RIN4: RPM1-interacting protein 4 |
| Cm178710 | 2.4288 | 0.0032793 | RIN4: RPM1-interacting protein 4 |
* Inf, Infinite (The denominator is zero.).
Figure 4Schematic depiction of the antiviral RNA silencing pathway with differentially expressed genes and their mRNA fold change based on RNA-sequencing (RNA-seq) analysis are shown. DCL2, DICER-LIKE 2; AGO2, ARGONAUTE 2; AGO7, ARGONAUTE 7; RDR1, RNA-DEPENDENT RNA POLYMERASE 1; SDE3, SILENCING DEFECTIVE 3; RISC, RNA-induced silencing complex.
Figure 5Validation of RNA-seq results by quantitative real-time PCR (RT-qPCR). Expression patterns of 12 representative genes as determined by RT-qPCR and RNA-seq. Normalization for RT-qPCR was performed using expression of the actin gene as an internal reference. CAHC: Carbonic anhydrase, chloroplastic; PAE8: Pectin acetylesterase 8; PLY5: Pectate lyase 5; LECR: Lectin-related protein; DCL2: Endoribonuclease Dicer homolog 2; SDE3: Silencing defective 3; MGL: Methionine gamma-lyase; PCNA: Proliferating cell nuclear antigen; GSTX2: Glutathione S-transferase; SAG12: Senescence-specific cysteine protease SAG12; PR4B: Pathogenesis-related protein PR-4B; GID1B: Gibberellin receptor GID1B.